Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease
- PMID: 22977588
- PMCID: PMC3440826
- DOI: 10.3892/etm.2011.316
Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease
Abstract
p16INK4a as a diagnostic marker of a cervical intraepithelial neoplasia of grade 2+ (CIN2+) in atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) cytological samples has been analyzed, but has not yet been included in clinical routine practice. One hundred and ninety-one patients with an abnormal Pap test (84 ASC-US and 107 LSILs) who underwent colposcopy were selected for this study. At enrollment, 96 patients (Group 1) had a positive colposcopy and therefore underwent a cervical biopsy, while 95 (Group 2) had a negative colposcopy and were followed up for up to 1 year. Both groups were tested for p16INK4a using immunocytochemical methods, and the p16INK4a results were correlated with histology or follow-up outcome. In Group 1 ASC-US cases, 82% of lesions less than CIN2 were p16INK4a-negative and all CIN2 cases were p16INK4a-positive (p=0.00044). In Group 1 LSIL cases, 71% of lesions less than CIN2 were p16INK4a-negative and 87% of CIN2/3 were p16INK4a-positive (p=0.00033). Seventy-seven percent of Group 2 ASC-US patients with a negative 1-year follow-up (NF-U) were p16INK4a-negative at enrollment, while all patients with positive follow-up (PF-U) were p16INK4a-positive (p=0.00113). In Group 2 LSIL cases, 83% of patients with NF-U were p16INK4a-negative, while 65% of patients with PF-U were p16INK4a-positive at enrollment (p=0.0014). In fact, 39% of the positive p16INK4a LSIL patients had CIN2+ histological lesions. The positive predictive value of p16INK4a for CIN2+ was 50% in ASC-US and 52% in LSIL cases; the negative predictive value was 100 and 94%, respectively. In conclusion, in our patients, a negative p16INK4a appears to be a marker of the absence of CIN3, while a positive p16INK4a can be correlated with the presence of histological CIN2+ found at enrollment or during the subsequent follow-up. Thus, its clinical predictive value is independent from the colposcopic aspect at enrollment.
Similar articles
-
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.Gynecol Oncol. 2019 Aug;154(2):360-367. doi: 10.1016/j.ygyno.2019.05.012. Epub 2019 May 31. Gynecol Oncol. 2019. PMID: 31160073
-
Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines.Obstet Gynecol Sci. 2017 Jul;60(4):357-361. doi: 10.5468/ogs.2017.60.4.357. Epub 2017 Jul 14. Obstet Gynecol Sci. 2017. PMID: 28791267 Free PMC article.
-
The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.Obstet Gynecol. 2010 Jul;116(1):76-84. doi: 10.1097/AOG.0b013e3181e3e719. Obstet Gynecol. 2010. PMID: 20567171
-
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).Am J Obstet Gynecol. 2006 Aug;195(2):341-8. doi: 10.1016/j.ajog.2006.02.047. Am J Obstet Gynecol. 2006. PMID: 16890545
-
The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology.J Am Soc Cytopathol. 2015 Sep-Oct;4(5):290-293. doi: 10.1016/j.jasc.2015.02.006. Epub 2015 Feb 23. J Am Soc Cytopathol. 2015. PMID: 31051767
Cited by
-
HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.Med Oncol. 2014 Mar;31(3):842. doi: 10.1007/s12032-014-0842-6. Epub 2014 Jan 17. Med Oncol. 2014. PMID: 24436016
-
Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review.Thorac Cancer. 2020 Nov;11(11):3060-3070. doi: 10.1111/1759-7714.13651. Epub 2020 Sep 18. Thorac Cancer. 2020. PMID: 32945604 Free PMC article. Review.
-
Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.Medicine (Baltimore). 2016 Jan;95(3):e2425. doi: 10.1097/MD.0000000000002425. Medicine (Baltimore). 2016. PMID: 26817873 Free PMC article.
References
-
- Zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55–F78. - PubMed
-
- Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R, Hong WK, Schottenfeld D. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr. 1996;21:17–25. - PubMed
-
- Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186–192. - PubMed
-
- Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346–355. - PubMed
-
- Gestione della paziente con Pap test anormale Linee guida 2006 a cura della Società Italiana di Colposcopia e Patologia Cervico Vaginale (SICPCV) Articoli Editore. Modena. (1st edition) 2006;21:2–26.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous